↑Stegmann K, Boecker J, Kosan C, Ermert A, Kunz J, Koch MC(August 1999).“Human transcription factor SLUG: mutation analysis in patients with neural tube defects and identification of a missense mutation (D119E) in the Slug subfamily-defining region”.Mutation Research406(2–4): 63–69.doi:10.1016/s1383-5726(99)00002-3.PMID10479723.
1234Inukai T, Inoue A, Kurosawa H, Goi K, Shinjyo T, Ozawa K, Mao M, Inaba T, Look AT(September 1999).“SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein”.Molecular Cell4(3): 343–352.doi:10.1016/S1097-2765(00)80336-6.PMID10518215.
123Carlson BM(2013).Human Embryology and Developmental Biology(5th ed.).Philadelphia, PA:Elsevier Health Sciences.pp.101–102, 106, 313, 362, 382.ISBN978-1-4557-2794-0
Maruyama K, Sugano S(January 1994).“Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”.Gene138(1–2): 171–174.doi:10.1016/0378-1119(94)90802-8.PMID8125298.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S(October 1997).“Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library”.Gene200(1–2): 149–156.doi:10.1016/S0378-1119(97)00411-3.PMID9373149.
Stegmann K, Boecker J, Kosan C, Ermert A, Kunz J, Koch MC(August 1999).“Human transcription factor SLUG: mutation analysis in patients with neural tube defects and identification of a missense mutation (D119E) in the Slug subfamily-defining region”.Mutation Research406(2–4): 63–69.doi:10.1016/S1383-5726(99)00002-3.PMID10479723.
Inukai T, Inoue A, Kurosawa H, Goi K, Shinjyo T, Ozawa K, Mao M, Inaba T, Look AT(September 1999).“SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein”.Molecular Cell4(3): 343–352.doi:10.1016/S1097-2765(00)80336-6.PMID10518215.
Hajra KM, Chen DY, Fearon ER(March 2002).“The SLUG zinc-finger protein represses E-cadherin in breast cancer”.Cancer Research62(6): 1613–1618.PMID11912130.
Sánchez-Martín M, Rodríguez-García A, Pérez-Losada J, Sagrera A, Read AP, Sánchez-García I(December 2002).“SLUG (SNAI2) deletions in patients with Waardenburg disease”.Human Molecular Genetics11(25): 3231–3236.doi:10.1093/hmg/11.25.3231.PMID12444107.
Catalano A, Rodilossi S, Rippo MR, Caprari P, Procopio A(November 2004).“Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells”.The Journal of Biological Chemistry279(45): 46706–46714.doi:10.1074/jbc.M406696200.PMID15337769.
Uchikado Y, Natsugoe S, Okumura H, Setoyama T, Matsumoto M, Ishigami S, Aikou T(February 2005).“Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma”.Clinical Cancer Research11(3): 1174–1180.doi:10.1158/1078-0432.1174.11.3.PMID15709186.
Chen M, Chen LM, Chai KX(June 2006).“Androgen regulation of prostasin gene expression is mediated by sterol-regulatory element-binding proteins and SLUG”.The Prostate66(9): 911–920.doi:10.1002/pros.20325.PMID16541421.
Turner FE, Broad S, Khanim FL, Jeanes A, Talma S, Hughes S, Tselepis C, Hotchin NA(July 2006).“Slug regulates integrin expression and cell proliferation in human epidermal keratinocytes”.The Journal of Biological Chemistry281(30): 21321–21331.doi:10.1074/jbc.M509731200.PMID16707493.